Compare Block Inc (XYZ) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Block Inc vs Zimmer Biomet Holdings Inc — how do they compare? Block Inc trades at $77.24 (market cap $45.20B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Block Inc is far larger — about 2.7× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Block Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Block Inc for 78 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| XYZ | ZBH | |
|---|---|---|
Market Cap | $45.20B | $16.95B |
Volume | 8,386,094 | 2,505,240 |
Sector | Technology | Health |
52-Week High | $84.85 | $103.98 |
52-Week Low | $49.04 | $79.58 |
Typical Hold Time | 78 Days | 89 Days |
Enterprise Value | $40.10B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
XYZ trades at $75.21, down 1.13% on the day, with technical indicators showing bearish momentum near key support at $74. The company reported mixed Q3 2026 earnings with two beats and one miss, while revenue growth has slowed to 0.4% year-over-year in 2025. Analyst consensus remains strongly bullish with a $97.47 price target, representing 30% upside potential from current levels.
XYZ faces valuation concerns with a high P/E ratio of 134.34, though strong institutional support and expanding merchant partnerships provide growth catalysts. Key risks include declining net income margins and negative cash flow trends, requiring careful monitoring of upcoming Q3 2026 results for directional clarity.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
